Newsfile Corp
16 Jun 2026, 19:47 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
GeneDx lowered its full-year revenue guidance to $475-$490 million from the previous $540-$550 million range. — A significant downward revision of annual revenue guidance typically leads to immediate valuation downgrades.
-0.70GeneDx reported a $31.2 million impairment loss related to its acquisition of Fabric Genomics. — Impairment charges indicate the company overpaid for an asset and failed to realize expected synergies or growth.
-0.60GeneDx experienced a drop in adjusted gross margin from 74% to 69% in Q1 2026. — Margin compression suggests decreasing profitability and potential operational inefficiency.
-0.40A securities class action lawsuit has been filed against GeneDx and its executives for allegedly failing to disclose material information. — Legal actions for securities fraud create overhang and potential financial liabilities for the company.
Continue reading
6 related stories
Top 3 movers · tap to explore
Which stocks this story touches
The company is facing a securities class action lawsuit following a 49% stock price drop, missed revenue estimates, and a $31.2 million impairment loss.
Mentioned regarding a securities class action resulting from undisclosed growth obstacles and a 70% stock decline.
Mentioned in the context of a securities fraud class action related to anticompetitive agreements and regulatory risks.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
34m ago
